| Style | Citing Format |
|---|---|
| MLA | Dasdar S, et al.. "Rituximab for the Treatment of Epidermolysis Bullosa Acquisita: A Large Case Series of 15 Patients." JDDG - Journal of the German Society of Dermatology, vol. 21, no. 7, 2023, pp. 779-784. |
| APA | Dasdar S, Kianfar N, Tavakolpour S, Balighi K, Mahmoudi H, Daneshpazhooh M (2023). Rituximab for the Treatment of Epidermolysis Bullosa Acquisita: A Large Case Series of 15 Patients. JDDG - Journal of the German Society of Dermatology, 21(7), 779-784. |
| Chicago | Dasdar S, Kianfar N, Tavakolpour S, Balighi K, Mahmoudi H, Daneshpazhooh M. "Rituximab for the Treatment of Epidermolysis Bullosa Acquisita: A Large Case Series of 15 Patients." JDDG - Journal of the German Society of Dermatology 21, no. 7 (2023): 779-784. |
| Harvard | Dasdar S et al. (2023) 'Rituximab for the Treatment of Epidermolysis Bullosa Acquisita: A Large Case Series of 15 Patients', JDDG - Journal of the German Society of Dermatology, 21(7), pp. 779-784. |
| Vancouver | Dasdar S, Kianfar N, Tavakolpour S, Balighi K, Mahmoudi H, Daneshpazhooh M. Rituximab for the Treatment of Epidermolysis Bullosa Acquisita: A Large Case Series of 15 Patients. JDDG - Journal of the German Society of Dermatology. 2023;21(7):779-784. |
| BibTex | @article{ author = {Dasdar S and Kianfar N and Tavakolpour S and Balighi K and Mahmoudi H and Daneshpazhooh M}, title = {Rituximab for the Treatment of Epidermolysis Bullosa Acquisita: A Large Case Series of 15 Patients}, journal = {JDDG - Journal of the German Society of Dermatology}, volume = {21}, number = {7}, pages = {779-784}, year = {2023} } |
| RIS | TY - JOUR AU - Dasdar S AU - Kianfar N AU - Tavakolpour S AU - Balighi K AU - Mahmoudi H AU - Daneshpazhooh M TI - Rituximab for the Treatment of Epidermolysis Bullosa Acquisita: A Large Case Series of 15 Patients JO - JDDG - Journal of the German Society of Dermatology VL - 21 IS - 7 SP - 779 EP - 784 PY - 2023 ER - |